Pharmsville Co. Ltd
Pharmsville Co., Ltd. produces and sells functional health food in South Korea. The company also exports its products. It offers its products under the Apple Tree Dr. Kim, Devil Diet, Sang Sang Bang, Vitamin Story, Apple Tree, Golden Garden, Daily Green, Wilac, Doctor Solution, and PS brands. Pharmsville Co., Ltd. was founded in 2000 and is headquartered in Seoul, South Korea.
Pharmsville Co. Ltd (318010) - Total Liabilities
Latest total liabilities as of September 2025: ₩2.58 Billion KRW
Based on the latest financial reports, Pharmsville Co. Ltd (318010) has total liabilities worth ₩2.58 Billion KRW as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Pharmsville Co. Ltd - Total Liabilities Trend (2017–2024)
This chart illustrates how Pharmsville Co. Ltd's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Pharmsville Co. Ltd Competitors by Total Liabilities
The table below lists competitors of Pharmsville Co. Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
A-Smart Holdings Ltd.
F:IOTA
|
Germany | €8.78 Million |
|
Utility Business Alliance PCL
BK:UBA
|
Thailand | ฿80.28 Million |
|
Great Divide Mining Ltd
AU:GDM
|
Australia | AU$424.04K |
|
Crown Lifters Limited
NSE:CROWN
|
India | ₹1.19 Billion |
|
Phapros Tbk PT
JK:PEHA
|
Indonesia | Rp1.06 Trillion |
|
Timberwell Bhd
KLSE:7854
|
Malaysia | RM14.94 Million |
|
Free Flow Inc
OTCQB:FFLO
|
USA | $2.08 Million |
Liability Composition Analysis (2017–2024)
This chart breaks down Pharmsville Co. Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 19.34 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.04 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.04 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Pharmsville Co. Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Pharmsville Co. Ltd (2017–2024)
The table below shows the annual total liabilities of Pharmsville Co. Ltd from 2017 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | ₩2.62 Billion | -64.45% |
| 2023-12-31 | ₩7.37 Billion | -39.99% |
| 2022-12-31 | ₩12.27 Billion | -18.76% |
| 2021-12-31 | ₩15.11 Billion | +12.89% |
| 2020-12-31 | ₩13.38 Billion | +7.84% |
| 2019-12-31 | ₩12.41 Billion | +89.50% |
| 2018-12-31 | ₩6.55 Billion | -33.48% |
| 2017-12-31 | ₩9.84 Billion | -- |